| For: | Hu WM, Li L, Jing BQ, Zhao YS, Wang CL, Feng L, Xie YE. Effect of S1P5 on proliferation and migration of human esophageal cancer cells. World J Gastroenterol 2010; 16(15): 1859-1866 [PMID: 20397263 DOI: 10.3748/wjg.v16.i15.1859] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1859.htm |
| Number | Citing Articles |
| 1 |
Mohamad Adada, Daniel Canals, Yusuf A. Hannun, Lina M. Obeid. Sphingosine-1-phosphate receptor 2. FEBS Journal 2013; 280(24) doi: 10.1111/febs.12446
|
| 2 |
Katrin G. Schmidt, Martina Herrero San Juan, Sandra Trautmann, Lucija Berninger, Anja Schwiebs, Florian M. Ottenlinger, Dominique Thomas, Frank Zaucke, Josef M. Pfeilschifter, Heinfried H. Radeke. Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01242
|
| 3 |
|
| 4 |
Franck Talmont, Elodie Mitri, Christine Dozier, Arnaud Besson, Olivier Cuvillier, Anastassia Hatzoglou. Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts. Cancers 2022; 14(7) doi: 10.3390/cancers14071661
|
| 5 |
Mohamad Bahij Moumneh, Tarek Bou Dargham, Marguerite Mrad, Ghassan Dbaibo. Handbook of Cancer and Immunology. 2023; doi: 10.1007/978-3-030-80962-1_264-1
|
| 6 |
Christin Wünsche, Alexander Koch, Roel Goldschmeding, Stephanie Schwalm, Dagmar Meyer zu Heringdorf, Andrea Huwiler, Josef Pfeilschifter. Transforming growth factor β2 (TGF-β2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(5) doi: 10.1016/j.bbalip.2015.01.003
|
| 7 |
Preeti Gupta, Aaliya Taiyab, Afzal Hussain, Mohamed F. Alajmi, Asimul Islam, Md. Imtaiyaz Hassan. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy. Cancers 2021; 13(8) doi: 10.3390/cancers13081898
|
| 8 |
Yuchan Wang, Shuhui Zhou, Xiaojing Yang, Hui Shi, Mei Li, Qun Xue, Xianting Huang, Xinxiu Wang, Huijie Wang, Jianguo Zhang. Low expression of cyclic amp response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma. Tumor Biology 2013; 34(6) doi: 10.1007/s13277-013-0946-1
|
| 9 |
Shailaja Mahajan-Thakur, Sandra Bien-Möller, Sascha Marx, Henry Schroeder, Bernhard H. Rauch. Sphingosine 1-Phosphate (S1P) Signaling in Glioblastoma Multiforme—A Systematic Review. International Journal of Molecular Sciences 2017; 18(11) doi: 10.3390/ijms18112448
|
| 10 |
Guillaume Andrieu, Adeline Ledoux, Sophie Branka, Magalie Bocquet, Julia Gilhodes, Thierry Walzer, Kousuke Kasahara, Masaki Inagaki, Roger A. Sabbadini, Olivier Cuvillier, Anastassia Hatzoglou.
Sphingosine 1-phosphate signaling through its receptor S1P
5
promotes chromosome segregation and mitotic progression
. Science Signaling 2017; 10(472) doi: 10.1126/scisignal.aah4007
|
| 11 |
Matteo Prisinzano, Isabelle Seidita, Paola Bruni, Felice Petraglia, Caterina Bernacchioni, Dagmar Meyer zu Heringdorf, Chiara Donati. Characterization of functionally relevant G protein-coupled receptors in endometriotic epithelial cells. Cellular Signalling 2025; 133 doi: 10.1016/j.cellsig.2025.111876
|
| 12 |
Zhen Zeng, Chunxiang Ma, Kexin Chen, Mingshan Jiang, Reshma Vasu, Rui Liu, Yinglan Zhao, Hu Zhang. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021; 10(11) doi: 10.3390/cells10112988
|
| 13 |
Qi Qin, Yumei Zhou, Mengzhao Feng, Kaiyuan Zhang, Minkai Wang, Zhenyu Zhang, Min Yu, Xianzhi Liu. BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels. The FASEB Journal 2025; 39(16) doi: 10.1096/fj.202501098RR
|
| 14 |
|
| 15 |
Lian Fang, Jiangtao Hou, Yihui Cao, Jia-Jie Shan, Jie Zhao. Spinster homolog 2 in cancers, its functions and mechanisms. Cellular Signalling 2021; 77 doi: 10.1016/j.cellsig.2020.109821
|
| 16 |
Fabian Cordts, Stuart Pitson, Christoph Tabeling, Ian Gibbins, David F. Moffat, Hubertus Jersmann, Sandra Hodge, Rainer V. Haberberger. Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease. Life Sciences 2011; 89(21-22) doi: 10.1016/j.lfs.2011.08.018
|
| 17 |
. 2018; doi: 10.70675/4f7c1702zf576z4f67z8913zeb5fdc0f59f6
|
| 18 |
Yan Chen, Jing Dai, Peng Chen, Quan Dai, Ya Chen, Yuying Li, Man Lu, Shugang Qin, Qiuju Wang. Long non-coding RNAs-sphingolipid metabolism nexus: Potential targets for cancer treatment. Pharmacological Research 2024; 210 doi: 10.1016/j.phrs.2024.107539
|
| 19 |
Tim F. Dorweiler, Timothy Hla. Apolipoprotein M: Structural insights, functional roles, and therapeutic approaches in vascular disease. Journal of Biological Chemistry 2026; 302(4) doi: 10.1016/j.jbc.2026.111335
|
| 20 |
Suriyan Ponnusamy, Marisa Meyers-Needham, Can E Senkal, Sahar A Saddoughi, David Sentelle, Shanmugam Panneer Selvam, Arelis Salas, Besim Ogretmen. Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance. Future Oncology 2010; 6(10) doi: 10.2217/fon.10.116
|
| 21 |
Chunyi Wang, Jinghe Mao, Samantha Redfield, Yinyuan Mo, Janice M. Lage, Xinchun Zhou. Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues. Experimental and Molecular Pathology 2014; 97(2) doi: 10.1016/j.yexmp.2014.07.013
|
| 22 |
Nidhi V. Dwivedi, Souvik Datta, Karim El‐Kersh, Ruxana T. Sadikot, Apar K. Ganti, Surinder K. Batra, Maneesh Jain. GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases. The FASEB Journal 2023; 37(8) doi: 10.1096/fj.202301091
|
| 23 |
Jessie W. Yester, Etsegenet Tizazu, Kuzhuvelil B. Harikumar, Tomasz Kordula. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer and Metastasis Reviews 2011; 30(3-4) doi: 10.1007/s10555-011-9305-0
|
| 24 |
Jinzhong Liu, Zhenfeng Li, Jing Cui, Gang Xu, Guanglin Cui. Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas. Tumor Biology 2012; 33(2) doi: 10.1007/s13277-011-0281-3
|
| 25 |
Xue, MS Jinru, Yang, MS Yu, Jiang, MD Bo, Qian, MD Linxue, Shi, PhD Xian-Quan. Identification of Key Genes Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma by Bioinformatics Analysis. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2020; 4(4) doi: 10.37015/AUDT.2020.200011
|
| 26 |
Mohamad Bahij Moumneh, Tarek Bou Dargham, Marguerite Mrad, Ghassan Dbaibo. Novel Approaches in Cancer Treatment. Handbook of Cancer and Immunology 2025; 8 doi: 10.1007/978-3-032-00771-1_264
|
| 27 |
Catherine Olesch, Christian Ringel, Bernhard Brüne, Andreas Weigert. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation. Mediators of Inflammation 2017; 2017 doi: 10.1155/2017/6059203
|
| 28 |
Paulette Tamashiro, Hideki Furuya, Yoshiko Shimizu, Kayoko Iino, Toshihiko Kawamori. The Impact of Sphingosine Kinase-1 in Head and Neck Cancer. Biomolecules 2013; 3(3) doi: 10.3390/biom3030481
|
| 29 |
Kati Kemppainen, Nina Wentus, Taru Lassila, Asta Laiho, Kid Törnquist. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Cellular Signalling 2016; 28(12) doi: 10.1016/j.cellsig.2016.09.004
|
| 30 |
Olga Sukocheva. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming. International Journal of Molecular Sciences 2018; 19(2) doi: 10.3390/ijms19020420
|
| 31 |
Ilari Pulli, Muhammad Yasir Asghar, Kati Kemppainen, Kid Törnquist. Sphingolipid-mediated calcium signaling and its pathological effects. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2018; 1865(11) doi: 10.1016/j.bbamcr.2018.04.012
|
| 32 |
Gabriela Schneider. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1223 doi: 10.1007/978-3-030-35582-1_7
|
| 33 |
Olga A. Sukocheva, Hideki Furuya, Mei Li Ng, Markus Friedemann, Mario Menschikowski, Vadim V. Tarasov, Vladimir N. Chubarev, Sergey G. Klochkov, Margarita E. Neganova, Arduino A. Mangoni, Gjumrakch Aliev, Anupam Bishayee. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacology & Therapeutics 2020; 207 doi: 10.1016/j.pharmthera.2019.107464
|
| 34 |
Sathya Narayanan Patmanathan, Wei Wang, Lee Fah Yap, Deron R. Herr, Ian C. Paterson. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cellular Signalling 2017; 34 doi: 10.1016/j.cellsig.2017.03.002
|
| 35 |
Mathieu Fortier, Nicolas Figeac, Robert B. White, Paul Knopp, Peter S. Zammit. Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells. Developmental Biology 2013; 382(2) doi: 10.1016/j.ydbio.2013.07.006
|
| 36 |
Peng Wang, Yonghui Yuan, Wenda Lin, Hongshan Zhong, Ke Xu, Xun Qi. Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1014-8
|
| 37 |
Eileen M. McGowan, Yiguang Lin, Size Chen. Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway. Cancers 2022; 14(3) doi: 10.3390/cancers14030535
|
| 38 |
Catherine Olesch, Bernhard Brüne, Andreas Weigert. Keep a Little Fire Burning—The Delicate Balance of Targeting Sphingosine-1-Phosphate in Cancer Immunity. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031289
|
| 39 |
Yuna Kim, Sungho Ghil. Negative regulation of cannabinoid receptor 2‑induced tumorigenic effect by sphingosine‑1‑phosphate receptor 5 activation. Oncology Reports 2025; 53(3) doi: 10.3892/or.2025.8874
|